Types of Research
- (-) Remove East Africa Region and Selected Countries filter East Africa Region and Selected Countries
- (-) Remove Global filter Global
- (-) Remove 2018 filter 2018
- (-) Remove Literature Review filter Literature Review
- (-) Remove 2013 filter 2013
Many low- and middle-income countries remain challenged by a financial infrastructure gap, evidenced by very low numbers of bank branches and automated teller machines (ATMs) (e.g., 2.9 branches per 100,000 people in Ethiopia versus 13.5 in India and 32.9 in the United States (U.S.) and 0.5 ATMs per 100,000 people in Ethiopia versus 19.7 in India and 173 in the U.S.) (The World Bank 2015a; 2015b). Furthermore, only an estimated 62 percent of adults globally have a banking account through a formal financial institution, leaving over 2 billion adults unbanked (Demirgüç–Kunt et al., 2015). While conventional banks have struggled to extend their networks into low-income and rural communities, digital financial services (DFS) have the potential to extend financial opportunities to these groups (Radcliffe & Voorhies, 2012). In order to utilize DFS however, users must convert physical cash to electronic money which requires access to cash-in, cash-out (CICO) networks—physical access points including bank branches but also including “branchless banking" access points such as ATMs, point-of-sale (POS) terminals, agents, and cash merchants. As mobile money and branchless banking expand, countries are developing new regulations to govern their operations (Lyman, Ivatury, & Staschen, 2006; Lyman, Pickens, & Porteous, 2008; Ivatury & Mas, 2008), including regulations targeting aspects of the different CICO interfaces.
EPAR's work on CICO networks consists of five components. First, we summarize types of recent mobile money and branchless banking regulations related to CICO networks and review available evidence on the impacts these regulations may have on markets and consumers. In addition to this technical report we developed a short addendum (EPAR 355a) which includes a description of findings on patterns around CICO regulations over time. Another addendum (EPAR 355b) summarizes trends in exclusivity regulations including overall trends, country-specific approaches to exclusivity, and a table showing how available data on DFS adoption from FII and GSMA might relate to changes in exclusivity policies over time. A third addendum (EPAR 355c) explores trends in CICO network expansion with a focus on policies seeking to improve access among more remote or under-served populations. Lastly, we developed a database of CICO regulations, including a regulatory decision options table which outlines the key decisions that countries can make to regulate CICOs and a timeline of when specific regulations related to CICOs were introduced in eight focus countries, Bangladesh, India, Indonesia, Kenya, Nigeria, Pakistan, Tanzania, and Uganda.
The private sector is the primary investor in health research and development (R&D) worldwide, with investment annual investment exceeding $150 billion, although only an estimated $5.9 billion is focused on diseases that primarily affect low and middle-income countries (LMICs) (West et al., 2017b). Pharmaceutical companies are the largest source of private spending on global health R&D focused on LMICs, providing $5.6 billion of the $5.9 billion in total private global health R&D per year. This report draws on 10-K forms filed by Pharmaceutical companies with the U.S. Securities and Exchange Commission (SEC) in the year 2016 to examine the evidence for five specific disincentives to private sector investment in drugs, vaccines and therapeutics for global health R&D: scientific uncertainty, weak policy environments, limited revenues and market uncertainty, high fixed costs for research and manufacturing, and imperfect markets. 10-K reports follow a standard format, including a business section and a risk section which include information on financial performance, investment options, lines of research, promising acquisitions and risk factors (scientific, market, and regulatory). As a result, these filings provide a valuable source of information for analyzing how private companies discuss risks and challenges as well as opportunities associated with global health R&D targeting LMICs.
This report provides a genderal overview of the sweet potato value chain in Ethiopia. The first section describes trends in sweet potato production and consumption since the early 1990s. The second section describes the uses and importance of sweet potatoes in Ethiopia. The final section discuss major issues in production, post-production, and marketing. The literature available on sweet potetoes in Ethiopia was quite limited and draws on the wider literature on sweet potatoes in East Africa where needed. We find that Ethiopia ranks fifteenth in the world in terms of sweet potato production. Production has been rising quickly since 2008, following a period of slow decline in the early 2000s. Yields have also been rising slowly since 2008, but are below their peak from 2001. Sweet potato roots are consumed domestically, mostly by poor rural households. The vines also provide an important source of feed for livestock during the dry season. Major constraints to sweet potato production in Ethiopia include a lack of quality planting materials, pests and disease, and underdeveloped markets.
Uganda is the biggest sweet potato producer in Africa in terms of area harvested and production, although Burundi, Rwanda and Madagascar have significantly higher yields. Sweet potato is a major crop in Uganda, ranking third in cultivated area following plantains and cassava. Sweet potato ranks fourth in gross agricultural production value. The Government of Uganda has recognized sweet potatoes as an important crop for the country and a research priority, especially through establishing the National Agricultural Research Organization potato center. This report provides a general overview of the sweet potato value chain in Uganda. The first section describes trends in sweet potato production and consumption since 1996. The second section describes the varieties grown and their uses. The final section summarizes current practices and constraints in production, processing, and marketing.